Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Bullish option flow detected in CVS Health (CVS) with 33,211 calls trading, 1.7x expected, and implied vol increasing over 7 points to 47.44%.

The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...

A state law that went into effect this week aims to regulate the role of third-party pharmacy benefit managers, who many say ...

CVS Caremark will add Zydus' ZituvioTM and combination products to its template formulary starting January 1, 2025 ...

Zydus Lifesciences reacted sharply to the development in Tuesday's trade with the counter rising 5.23 percent to an intraday high of Rs 1,011.75 per share on the NSE.

CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and ...

Three laws regarding the healthcare industry will see an impact on both staff and patients in Washington and Idaho on January 1, 2025.

Businesspeople, healthcare workers, a teacher and a former England football manager are among those from the Harrogate District to receive awards in The King’s New Year Honours List 2025.

Out of all of the special options we uncovered, 6 are puts, for a total amount of $241,558, and 4 are calls, for a total ...

Netflix scores a hit with Christmas Day NFL games, how Medicare plans, working with PBMs, fueled opioid sales, and more news to start your day.

The U.S. Justice Department is suing pharmacy giant CVS, accusing it of putting profits over patient safety and thus fueling the opioid crisis. The accusations bear similarities to violations for ...